Tamarac, FLNCT06892379Now EnrollingIRB Ready

Solid Tumors Clinical Trial in Tamarac, FL

Access cutting-edge solid tumors treatment through this clinical trial at a research site in Tamarac. Study-provided care at no cost to qualified participants.

Sponsored by Hansoh BioMedical R&D Company

Quick Self-Assessment

See if you qualify for this Tamarac location

Preparing your pre-screening questions…

Expert Care in Tamarac

Access solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related solid tumors treatment provided free

Apply for This Tamarac Location

Check if you qualify for this solid tumors clinical trial in Tamarac, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tamarac

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tamarac site if eligible
  4. 4Begin participation

About This Solid Tumors Study in Tamarac

This is an open-label, multicenter study to evaluate the safety and tolerability of HS-20110 in participants with advanced solid malignant tumors

Sponsor: Hansoh BioMedical R&D Company

Who Can Participate

Inclusion Criteria

Males or females, aged ≥ 18 years.
Participants with pathologically (histologically or cytologically) confirmed advanced solid tumors.
Participants have at least 1 target lesion other than CNS lesions according to RECIST 1.1.

Exclusion Criteria

Participants have received or are receiving the following treatment:
Drug therapy targeting CDH17 (such as small molecule targeted drugs, monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, or chimeric antigen receptor T cells).
Anti-tumor drugs within 14 days prior to the first dose of study treatment; any other IMPs or macromolecular anti-tumor drugs within 28 days prior to the first dose of study treatment.
Local radiotherapy within 2 weeks prior to the first dose of study treatment; irradiation of more than 30% of bone marrow or extensive radiotherapy within 4 weeks prior to the first dose of study treatment.
Major surgery within 4 weeks prior to the first dose of study treatment.
Participants previously treated with drugs that are moderate to strong inhibitors or moderate to strong inducers of cytochrome P450 (CYP) 3A4, strong inhibitors or strong inducers of CYP2D6, P-glycoprotein (P-gp), breast cancer resistance protein (BCRP) or drugs with a narrow therapeutic range that are sensitive substrates of P-gp or BCRP within 7 days prior to the first dose of the IMP. Participants who need to receive these drugs during the study period should also be excluded.
Current use of drugs known to prolong the QT interval or that may cause torsade de pointes. Participants who need to receive these drugs during the study period should also be excluded.
Live vaccine or live-attenuated vaccine within 28 weeks prior to the first dose.
Participants who have any Grade ≥ 2 residual toxicity according to Common Terminology Criteria for Adverse Events (CTCAE, version 5.0) from prior therapies (except alopecia and residual neurotoxicity).
Inadequate bone marrow reserve or hepatic and renal functions.
Participants with a history of severe allergy (such as anaphylactic shock), previous severe infusion reactions, or allergy to recombinant human or murine proteins.
Participants who are allergic to any component of HS-20110.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tamarac?

Yes, this clinical trial (NCT06892379) has an active research site in Tamarac, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumors Treatment Options in Tamarac, FL

If you're searching for solid tumors treatment options in Tamarac, FL, this clinical trial (NCT06892379) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tamarac research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumors clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Tamarac, FL

See all advanced solid tumors clinical trials recruiting in Tamarac — not just this study.

Browse Advanced Solid Tumors Trials in Tamarac →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAll Conditions →

Ready to Join in Tamarac?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tamarac, FL